Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
本发明公开了化合物和组合物,其中季
铵化药物单元与靶向
配体单元相连,含叔胺的药物从
配体单元中释放到靶向作用部位。还公开了使用本发明化合物和组合物治疗以靶向异常细胞为特征的疾病(如癌症或自身免疫性疾病)的方法。